2023
Artificial-Intelligence-Driven Algorithms for Predicting Response to Corticosteroid Treatment in Patients with Post-Acute COVID-19
MYSKA, Vojtech, Samuel GENZOR, Anzhelika MEZINA, Radim BURGET, Jan MIZERA et. al.Základní údaje
Originální název
Artificial-Intelligence-Driven Algorithms for Predicting Response to Corticosteroid Treatment in Patients with Post-Acute COVID-19
Autoři
MYSKA, Vojtech (203 Česká republika, garant), Samuel GENZOR (203 Česká republika), Anzhelika MEZINA (203 Česká republika), Radim BURGET (203 Česká republika), Jan MIZERA (203 Česká republika), Michal STYBNAR (203 Česká republika), Martin KOLARIK (203 Česká republika), Milan SOVA (203 Česká republika, domácí) a Malay Kishore DUTTA
Vydání
Diagnostics, Basel, MDPI, 2023, 2075-4418
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30203 Respiratory systems
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.600 v roce 2022
Kód RIV
RIV/00216224:14110/23:00133302
Organizační jednotka
Lékařská fakulta
UT WoS
000998282700001
Klíčová slova anglicky
personalised medication recommendation algorithms; artificial intelligence; post-COVID syndrome; prediction model; respiratory system; corticosteroids; eHealth
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 4. 2024 09:21, Mgr. Tereza Miškechová
Anotace
V originále
Pulmonary fibrosis is one of the most severe long-term consequences of COVID-19. Corticosteroid treatment increases the chances of recovery; unfortunately, it can also have side effects. Therefore, we aimed to develop prediction models for a personalized selection of patients benefiting from corticotherapy. The experiment utilized various algorithms, including Logistic Regression, k-NN, Decision Tree, XGBoost, Random Forest, SVM, MLP, AdaBoost, and LGBM. In addition easily human-interpretable model is presented. All algorithms were trained on a dataset consisting of a total of 281 patients. Every patient conducted an examination at the start and three months after the post-COVID treatment. The examination comprised a physical examination, blood tests, functional lung tests, and an assessment of health state based on X-ray and HRCT. The Decision tree algorithm achieved balanced accuracy (BA) of 73.52%, ROC-AUC of 74.69%, and 71.70% F1 score. Other algorithms achieving high accuracy included Random Forest (BA 70.00%, ROC-AUC 70.62%, 67.92% F1 score) and AdaBoost (BA 70.37%, ROC-AUC 63.58%, 70.18% F1 score). The experiments prove that information obtained during the initiation of the post-COVID-19 treatment can be used to predict whether the patient will benefit from corticotherapy. The presented predictive models can be used by clinicians to make personalized treatment decisions.